A study out of Brazil suggests that a simple, low-cost supplement could meaningfully improve how well chemotherapy works against breast cancer. Researchers at the Botucatu School of Medicine at São Paulo State University (FMB-UNESP) found that women who took daily vitamin D alongside chemotherapy were 79% more likely to achieve complete tumor disappearance than women who took a placebo.
At a glance
- Vitamin D supplementation: Women took 2,000 IU of vitamin D daily during chemotherapy — a modest, cost-effective dose rather than a high corrective one.
- Complete response rate: 43% of women in the vitamin D group saw their cancer fully disappear, compared to 24% in the placebo group.
- Study population: 80 women aged 45 and older, all receiving chemotherapy before surgery to shrink their tumors, most of whom were vitamin D-deficient at the start.
Why this finding matters
Breast cancer is the most commonly diagnosed cancer in women worldwide. Chemotherapy before surgery — called neoadjuvant chemotherapy — is a standard approach for many patients, and how completely the tumor responds to that treatment is a strong predictor of long-term outcomes.
A therapy that costs a few dollars a month and could raise the complete response rate by that margin is worth taking seriously. The researchers note that vitamin D is widely available, easy to take, and carries a well-established safety profile at this dose.
Most women in the study were deficient in vitamin D before treatment began — a common finding in cancer patients and in the general population. Correcting that deficiency during chemotherapy may have given the immune system more to work with.
How vitamin D may support cancer treatment
Vitamin D is best known for its role in bone health, but its influence on the immune system runs deeper. It helps regulate immune cell activity and has been shown in lab studies to affect how cancer cells grow and die. The UNESP researchers believe restoring adequate vitamin D levels may help the body respond more aggressively to the cancer during treatment.
What makes the UNESP approach notable is the dose. Rather than using the high supplementation levels sometimes used to rapidly correct deficiency, the team used 2,000 IU daily — a level considered safe for long-term use and practical for integration into a standard treatment plan.
Limitations and next steps
The researchers are careful not to overstate the results. The trial included only 80 participants, and the findings have not yet been replicated at scale. Larger, randomized clinical trials are needed before vitamin D can be formally recommended as a routine add-on for breast cancer chemotherapy.
Still, the direction of the finding is clear and the cost of further investigation is low. The research was published in a peer-reviewed oncology context and adds to a growing body of evidence linking nutritional status and cancer treatment outcomes.
Vitamin D deficiency is also not evenly distributed. Populations with darker skin tones, limited sun exposure, and lower incomes face higher deficiency rates — meaning an affordable supplement-based intervention could matter most for communities that already face worse cancer outcomes. That equity angle is one more reason researchers say follow-up work is urgent.
For now, the UNESP team recommends that oncologists consider testing patients’ vitamin D levels at the start of treatment. Supplementation at a modest dose carries little risk and, if this study holds up, may meaningfully shift the odds in a patient’s favor.
Read more
For more on this story, see: OnlyMyHealth
For more from Good News for Humankind, see:
- U.K. cancer death rates fall to their lowest level on record
- Alzheimer’s risk cut in half by drug in landmark prevention trial
- The Good News for Humankind archive on global health
About this article
- 🤖 This article is AI-generated, based on a framework created by Peter Schulte.
- 🌍 It aims to be inspirational but clear-eyed, accurate, and evidence-based, and grounded in care for the Earth, peace and belonging for all, and human evolution.
- 💬 Leave your notes and suggestions in the comments below — I will do my best to review and implement where appropriate.
- ✉️ One verified piece of good news, one insight from Antihero Project, every weekday morning. Subscribe free.
More Good News
-
More than 50 nations attend world-first conference on phasing out fossil fuels
Fossil fuel phaseout talks just crossed a real threshold: for the first time, more than 50 nations sat down together specifically to plan a way off coal, oil, and gas. The two-day gathering in Santa Marta, Colombia, brought together an unusually wide mix — major producers like Australia, Norway, and Canada alongside Pacific island nations like Tuvalu and Vanuatu, with Europe and emerging economies in between. No binding deals were expected, but the recommendations will feed into a voluntary roadmap being shaped under Brazil’s COP30 leadership. It’s a small, hopeful shift: producers and consumers finally talking openly about a transition…
-
Singapore bans sourcing and breeding dolphins
Resorts World Sentosa, home to more than 20 Indo-Pacific bottlenose dolphins, is halting both wild sourcing and captive breeding at its Singapore oceanarium. The resort is now assembling an independent expert panel to figure out what’s next for the animals in its care, including a 7-year-old named Kenzo. It’s a meaningful shift from one of Asia’s most prominent entertainment venues, and one animal welfare groups have pushed toward for over a decade. With Mexico, Canada, and France already banning cetacean captivity for entertainment, this quiet decision in Singapore signals that the tide is turning across Asia too, reshaping what travelers…
-
The Bahamas officially eliminates mother-to-child transmission of HIV
The Bahamas just became the 12th country or territory in the Americas certified by the World Health Organization for eliminating mother-to-child HIV transmission — meaning babies born there now enter the world free of the virus by design, not by luck. The country built this through a quietly powerful idea: every pregnant woman, regardless of nationality or legal status, gets HIV screening at her first prenatal visit and again later in pregnancy, with treatment and follow-up offered free. Reaching that standard across more than 700 scattered islands took years of coordination between nurses, doctors, and public clinics. More than half…
